510(k) device
AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC)
Trudell Medical International · Holding Chambers, Direct Patient Interface (NVP, Class II) · First FDA decision Jan 11, 2019, newest Jan 11, 2019AsthmaCOPD and emphysema
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
8
Naming "AeroChamber Plus Flow-Vu"
MAUDE reports
1
Brand "AeroChamber Plus Flow-Vu", since 2015
PubMed studies
2
Mentioning "AeroChamber Plus Flow-Vu"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K181649 · Decided Jan 11, 2019 · 203 days after receipt
Device type: Holding Chambers, Direct Patient Interface (NVP) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AeroChamber Plus Flow-Vu", any status and sponsor, newest update first.
- Advancing Diagnosis and Treatment of Pediatric AsthmaPivotal-lookingRecruiting
Luxembourg Institute of HealthGovernment (non-federal)
NCT07500246 · 208 participants (planned) · Start Jan 2, 2026 · Primary completion Aug 2027
Device: Whizz spacer system; AeroChamber Plus® Flow-Vu® · For: Asthma Childhood; Asthma; Inhalation Spacers
Sites: Liège, Belgium; Luxembourg, Luxembourg
AstraZenecaNot on our public-company list
NCT06340581 · 0 participants · Start Oct 17, 2024 · Primary completion Feb 27, 2025
Device: AeroChamber Plus Flow-Vu Spacer · For: Healthy
AstraZenecaNot on our public-company list
NCT06297668 · 42 participants · Start Apr 29, 2024 · Primary completion Jun 11, 2024
Device: AeroChamber Plus Flow-Vu spacer · For: Chronic Obstructive Pulmonary Disease
Sites: Berlin, Germany
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AeroChamber Plus Flow-Vu", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code NVP
14 reports: 6 malfunction, 7 injury, 0 death
Newest reports for this brand
MW5112406 · Received Oct 3, 2022 · Event dated Feb 1, 2000
Device type: Holding Chambers, Direct Patient Interface (NVP)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Hypersensitivity/Allergic reaction; Skin Burning Sensation
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- AEROCHAMBER PLS W/MASK LRG BLU Item Number: 1496033Open, Classified
Z-1932-2021 · Started Mar 16, 2021
Reason given: Due to shipping delays the devices were exposed to temperature excursions of 31.9F, intermittently over a 2 hour and 15 minute period of time which may cause inaccurate results.
Cause as FDA categorized it: Environmental control · Device type: Holding Chambers, Direct Patient Interface (NVP)
Published research
The most relevant PubMed records for "AeroChamber Plus Flow-Vu"[tiab]. The summary above synthesizes these.
- In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1-5-year-old children with persistent asthmatic symptoms.
Wachtel H, Nagel M, Engel M, et al. · Respir Med · 2018Clinical Trial, Comparative Study
- Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a Spacer.
Pandya H, Patel M, Gillen M, et al. · Clin Ther · 2026Clinical Trial, Phase I, Randomized Controlled Trial
Other devices of this type
Also filed under product code NVP.
- AeroChamber2go Anti-Static Valved Holding ChamberTrudell Medical International · 510(k) 2025
- LiteAire Basic Dual-Valved, Collapsible MDI Holding ChamberThayer Medical Corporation · 510(k) 2022
- Thayer Medical LiteAire Dual-valved, Collapsible MDI Holding ChamberThayer Medical Corporation · 510(k) 2017
- Antistatic Compact Space ChamberMedical Developments International Limited · 510(k) 2016
- Fsc Anti-Static Valved Collapsible Holding ChamberFsc Laboratories, Inc. · 510(k) 2014
- Space Chamber Plus Compact Space Chamber PlusMedical Developments International · 510(k) 2013
- Inspirachamber Anti-Static Valved Holding ChamberInspirx, Inc. · 510(k) 2013
- Aerochamber Plus Flow-Vu Anti-Static Valved Holding Chamber (Vhc)Trudell Medical Intl. · 510(k) 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.